Table 2

Qualitative baseline variables

Variable Placebo (n=160) Olsalazine (n=167)
Sex
 Male80  (50)70  (41.9)
 Female80 (50)97 (58.1)
Disease at ileocaecal junction79 (49.4)89 (53.3)
Disease in colon155 (96.9)157 (94.0)
100% of large bowel remaining119 (74.4)116 (69.5)
100% of small bowel remaining121 (75.6)119 (71.3)
Formed stools present86 (53.8)71 (42.8)
Concurrent illnesses41 (25.6)34 (20.4)
Bowel surgery performed43 (26.9)59 (35.3)
Current treatment to prevent relapse94 (58.8)99 (59.3)
  • Values are n (%).